SUBSCRIBE
SUBSCRIBE

BioSpace News Archive

Browse BioSpace’s published news and press releases by year, month, and day.
223 Results
Year
Month
Day
Year
Month
Day
  • FDA
    FDA approves QALSODY™ (tofersen) as the first treatment targeting a genetic cause of ALS
    Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that its partner Biogen has received U.S. Food and Drug Administration (FDA) approval of QALSODY™ (tofersen) 100 mg/15mL injection for the treatment of amyotrophic lateral sclerosis (ALS) in adults who have a mutation in the superoxide dismutase 1 (SOD1) gene.
    April 25, 2023
     · 
    12 min read
  • BioForest
    AGC Biologics Received Bioprocessing Excellence Award in Japan
    AGC Biologics announced it has received the “Bioprocessing Excellence in Japan” award at the Asia-Pacific Bioprocessing Excellence Awards ceremony for the work and achievements at the AGC Biologics Chiba, Japan site.
    April 25, 2023
     · 
    3 min read
  • BioCapital
    RemeGen Celebrates World Intellectual Property Day 2023
    RemeGen Co., Ltd., a commercial-stage biotechnology company, is celebrating World Intellectual Property Day 2023 which falls on April 26, the theme of which mirrors the critical importance RemeGen places on intellectual property rights for its accelerated innovation and creativity.
    April 25, 2023
     · 
    3 min read